New Insights into Kidney Disease Development and Therapy Strategies

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: 1 October 2024 | Viewed by 578

Special Issue Editors


E-Mail Website
Guest Editor

Special Issue Information

Dear Colleagues,

Basic science and practical issues related to etiological factors, methodology of analysis, diagnostic criteria, and therapeutic advances of neoplastic and non-neoplastic renal diseases are welcomed in this Special Issue, from renal epithelial/non-epithelial tumors to hereditary diseases, transplantation-related disorders, and glomerulonephritis. The Issue intends to bring together the experience of very different fields and serve as a unified forum for basic researchers, urologists, nephrologists, oncologists, pathologists, radiologists, and other related specialties.

You may choose our Joint Special Issue in Cancers.

Dr. José I. López
Dr. Claudia Manini
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

21 pages, 1391 KiB  
Review
Navigating the Evolving Landscape of Primary Hyperoxaluria: Traditional Management Defied by the Rise of Novel Molecular Drugs
by Yueqi Huang, Wei Zhu, Jia Zhou, Qiulin Huang and Guohua Zeng
Biomolecules 2024, 14(5), 511; https://doi.org/10.3390/biom14050511 - 23 Apr 2024
Viewed by 360
Abstract
Primary hyperoxalurias (PHs) are inherited metabolic disorders marked by enzymatic cascade disruption, leading to excessive oxalate production that is subsequently excreted in the urine. Calcium oxalate deposition in the renal tubules and interstitium triggers renal injury, precipitating systemic oxalate build-up and subsequent secondary [...] Read more.
Primary hyperoxalurias (PHs) are inherited metabolic disorders marked by enzymatic cascade disruption, leading to excessive oxalate production that is subsequently excreted in the urine. Calcium oxalate deposition in the renal tubules and interstitium triggers renal injury, precipitating systemic oxalate build-up and subsequent secondary organ impairment. Recent explorations of novel therapeutic strategies have challenged and necessitated the reassessment of established management frameworks. The execution of diverse clinical trials across various medication classes has provided new insights and knowledge. With the evolution of PH treatments reaching a new milestone, prompt and accurate diagnosis is increasingly critical. Developing early, effective management and treatment plans is essential to improve the long-term quality of life for PH patients. Full article
(This article belongs to the Special Issue New Insights into Kidney Disease Development and Therapy Strategies)
Show Figures

Figure 1

Back to TopTop